Remote Managing Board meeting

On 21st September 2020, the Hypo-RESOLVE Managing Board met virtually to present work progress, discuss future steps and also evaluate the impact the COVID-19 pandemic is having on the project’s progress and timeline. Apart from presenting the progress made since the last Managing Board meeting in February in Frankfurt – one particular success being the transferral of 100% of the trials to the database – the partners also engaged in intensive discussions on how to align work in order to minimize disruptions. Particularly carrying out clinical studies during this pandemic poses some challenges and patients first visits will therefore be handled virtually to avoid hospital visits that might expose them to COVID-19 infection risks.